About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,618 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,618 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1781-1800 of 6,618 trials

CompletedNeurobiological and Psychological Benefits of Exercise in Chronic Pain and PTSDThe wars in Iraq and Afghanistan are creating a new generation of Veterans, including an increasing number of women Veterans, who present with comorbid PTSD and chronic pain…NCT03283163·Boston, Massachusetts Enrolling by invitationADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin LymphomaReduced activity levels and reduced muscular strength could severely impair the activities of daily living (ADLs) in pediatric leukemia and Non-Hodgkin lymphoma patients.NCT05235633·Munich UnknownAnti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma PatientsThe goal of this clinical trial is to study the feasibility and efficacy of anti-CD22:TCRz:4-1BB chimeric antigen receptor (CAR)-modified T (CAR-T) cells in treating recurrent…NCT02721407·Chongqing, Chongqing Municipality

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

UnknownAutologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell LymphomaThis is a single-center, open-label and pragmatic clinical trial to evaluate the primary efficacy and safety of anti-CD19 chimeric antigen receptor (CAR)-modified T cells…NCT05020392·Wuhan, Hubei

CompletedForodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell LymphomaRATIONALE: Forodesine (BCX-1777) may stop the growth of cancer cells by blocking the enzymes necessary for their growth.NCT00098332·Birmingham, Alabama and 9 others

CompletedStudy to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate PneumoniaEarly inhibition of entry and replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a very promising therapeutic approach.NCT04453384·Amiens and 33 others

CompletedPanobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory LymphomaObjectives: Primary: * Determine the maximum tolerated dose (MTD) and dose limiting toxicity (DLT) of the novel combination of everolimus + Panobinostat (LBH589) in a phase-I…NCT00967044·Houston, Texas

RecruitingPreliminary Assessment of [18F]BL40 in PET/CT ScansCXCR4 is type of receptor that has been detected in more than twenty different subtypes of cancers.NCT06224309·Vancouver, British Columbia

UnknownA Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)The objective of this study is to evaluate efficacy and safety of TQ-B3101 in subjects with relapsed/refractory anaplastic large cell lymphoma (ALCL) .NCT04306887·Guangzhou, Guangdong

Active not recruitingCopanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin LymphomaThis phase I trial studies the best dose and how well copanlisib when given together with nivolumab works in treating patients with Richter's transformation or transformed…NCT03884998·Duarte, California and 2 others

RecruitingTissue Repository: CTCL Collection ProtocolThis document is a protocol for a non-interventional human research study in which the investigator hopes to better understand the changes that take place in T cells in Cutaneous…NCT02840747·New York, New York

Active not recruitingDose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell LymphomaThis phase II study will evaluate whether a reduction in radiation dose and field size will maintain a high rate of local control while minimizing the risk of acute and late…NCT03681535·Boston, Massachusetts and 11 others

CompletedGlutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With CancerRATIONALE: Glutamic acid may help lessen or prevent nerve damage caused by vincristine.NCT00369564·Fort Myers, Florida and 5 others

TerminatedPhase 1 Study of CC-486 in Japanese Subjects With Hematological NeoplasmsTo identify the maximum tolerated dose (MTD) of oral azacitidine on different treatment schedules in Japanese subjects with hematological neoplasmsNCT01908387·Kashiwa, Chiba and 2 others

CompletedInfusion of Allogeneic CD19-Specific T Cells From Peripheral BloodThe goal of this clinical research study is to learn if researchers can successfully and safely give HSCT patients an infusion of white blood cells (called T-cells) that have been…NCT01497184·Houston, Texas

Active not recruitingRituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete RemissionThis phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual…NCT03267433·Birmingham, Alabama and 374 others

Active not recruitingImatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaThis randomized phase III trial studies how well imatinib mesylate works in combination with two different chemotherapy regimens in treating patients with newly diagnosed…NCT03007147·Birmingham, Alabama and 225 others

CompletedVNP40101M in Treating Patients With Advanced or Metastatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00049699·New Haven, Connecticut and 2 others

CompletedBone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerRATIONALE: Bone marrow and peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor…NCT00004232·Chicago, Illinois

RecruitingA Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaThis feasibility trial studies how well daratumumab in combination with dose-adjusted etoposide, prednisone, vincristine sulfate, cyclophosphamide, and doxorubicin hydrochloride…NCT04139304·Miami, Florida and 7 others

PreviousPage 90 of 331Next